Purpose: To compare the central corneal epithelial thickness (CET), stromal thickness (CST), and total thickness (CCT) in males with and without primary open-angle glaucoma and to determine the factors associated with corneal thickness.
G laucoma is the leading cause of irreversible blindness and the second leading cause of vision loss worldwide. Although presently affecting more than 60 million people globally, the number is estimated to increase to 111.8 million by 2040. 1, 2 Glaucoma consists of a group of diseases defined by optic nerve damage. Primary open-angle glaucoma (POAG) is the most common subtype of glaucoma in the United States. 3 Early diagnosis and treatment of glaucoma have been shown to slow or prevent disease progression and minimize glaucoma-related vision loss. 3 Although the biological mechanisms of POAG are not yet well understood, several significant risk factors have long been linked to POAG, including elevated intraocular pressure (IOP), advanced age, black American race, and positive family history of glaucoma. [4] [5] [6] [7] More recently, central corneal total thickness (CCT) has also been shown to be a significant predictor of development of POAG in patients with ocular hypertension. 8 Other retrospective analyses have indicated that thinner CCT is a risk factor for glaucoma development and progression. [9] [10] [11] Several potential mechanisms have been postulated regarding the link between CCT and glaucoma. First, the relationship may be driven by IOP measurement errors because thinner corneas underestimate true IOP and thicker corneas overestimate the measurement. [12] [13] [14] Second, CCT may relate to the biomechanics of the optic nerve head. Because of the continuity of the cornea, sclera, and optic disc lamina, researchers have hypothesized that CCT may reflect the propensity of the sclera and lamina cribrosa to deform. 15, 16 However, the latter hypothesis has been questioned because some studies found insignificant correlations between CCT and optic disc lamina cribrosa distortion. 17, 18 Third, lower CCT may allow more oxygen in the anterior chamber angle, leading to oxidative damage to the trabecular meshwork cells, and increased IOP. 19 Fourth, CCT could constitute a biomarker for a glaucomatous genotype, in which some genes influencing CCT may also act in other tissues of more direct glaucoma relevance, such as the trabecular meshwork, retinal nerve fiber layer, or lamina cribrosa. 20 Given these discrepancies, it is uncertain whether CCT is an independent risk factor for glaucoma or simply a potential source of error in IOP measurements. 21 CCT can be measured using a variety of devices, such as ultrasound pachymetry, confocal microscopy, and anterior segment optical coherence tomography (AS-OCT). In most of these devices, CCT is measured as the combined thickness of the 3 major corneal histological layers including the epithelium, stroma, and endothelium. An advantage of AS-OCT is that it is a reliable and reproducible instrument for imaging the central cornea and can measure the corneal epithelium and stromal layer separately. 22, 23 Because the corneal stromal layer makes up more than 90% of the total corneal thickness, it has been postulated that disparities in this tissue layer are the primary cause of variability in corneal thickness. 24, 25 Nonetheless, the association between individual layers of corneal thickness measurements and POAG has not been fully investigated.
Previous studies have evaluated differences in some, but not all, corneal thickness measurements in patients with glaucoma compared with controls. For example, 1 study found no significant changes in central corneal epithelial thickness (CET) measurements between POAG and controls. 26 However, a knowledge gap remains regarding differences in epithelial and stromal thicknesses in glaucomatous and nonglaucomatous eyes. To fill in this knowledge gap, in this study, we compared epithelial, stromal, and total corneal thickness measurements in men with and without POAG using AS-OCT and evaluated which factors were linked to each individual corneal parameter.
METHODS

Study Population
Individuals who had undergone AS-OCT imaging of their central cornea (performed to measure CCT for many indications including precataract planning, glaucoma management, etc.) were identified. Of note, ultrasound pachymetry is not used in our clinic for this indication because it requires contact with the cornea and the processing requirement between uses is cumbersome. Individuals were divided into 2 groups based on glaucoma status (POAG vs. nonglaucoma group). POAG cases were defined as those with 2 or more of the following: IOP $ 21 mm Hg, optic nerve abnormalities (as defined by the treating physician), and/or imaging abnormalities (visual field and/or nerve fiber layer optical coherence tomography). Controls were defined as healthy individuals with no evidence of glaucoma in either eye (no history of elevated IOP; optic nerve or imaging abnormalities). Exclusion criteria were individuals with known corneal abnormalities (keratoconus or corneal scar). We also excluded females from the analysis because they compromised only a small portion of our population (n = 4). It was determined that 56 individuals were needed in each group to test for differences in mean CCT between individuals with and without POAG. This was based on an expected mean CCT difference of 8 mm (SD 15 mm), power of 80%, and a significance level of 0.05. The study was conducted in accordance with the principles of the Declaration of Helsinki and received approval from the Institutional Review Board (IRB) committee at the Miami Veteran Affairs Medical Center (VA).
Data Collection
Demographics (age, race, sex, and ethnicity), medical history (diabetes mellitus, hypertension, and hyperlipidemia), and ocular history (glaucoma severity and glaucoma medication use) were collected from medical records. Glaucoma severity was rated clinically through review of the medical record (including optic nerve photographs, optical coherence tomography images, and visual fields). The severity scale was based on the International Classification of Disease (ICD-9) Staging Criteria 27 as follows: stage 1: mild or early stage glaucoma, which is characterized by optic nerve abnormalities consistent with glaucoma but without visual field abnormalities on any visual field test; stage 2: moderate stage glaucoma, which was characterized by glaucomatous visual field abnormalities in 1 hemifield and not within 5 degrees of fixation; stage 3: severe or late stage glaucoma characterized by glaucomatous visual field abnormalities in both hemifields and/or loss within 5 degrees of fixation in at least 1 hemifield. The anterior segment module of the Cirrus HD-OCT (Carl Zeiss Meditec Inc, Dublin, CA) 26, 28 with the anterior segment 5-line raster was used to image the central cornea. After imaging, the best scan (of 5 images) was selected based on the clarity of corneal layers after magnification. Although most individuals had images available from both eyes, only the right eye of each was selected given the substantial correlation between corneal thickness measurements in the right and left eyes [central corneal total thickness (CCT); r = 0.9, central corneal stromal thickness (CST); r = 0.9, and central corneal epithelial thickness (CET); r = 0.5, P value = 0.00005 for all]. Lubricating drops or local anesthesia were not administrated before the scan.
Image Analysis
and black corneal images were magnified (by 600%-800%), and the corneal thickness was manually measured. 1) To measure CET, cursors were placed perpendicular to the ocular surface epithelium from a point located just beneath the tear film (first hyperreflective layer) to the basal membrane (second hyperreflective layer). 2) To measure CST, cursors were placed perpendicular to the ocular surface stroma from a point located just beneath the basal membrane (second hyperreflective layer) to Descemet membrane just above the endothelial layer (third hyperreflective layer). 3) To measure CCT, cursors were placed perpendicular to the ocular surface epithelium from a point located just beneath the tear film (first hyperreflective layer) to a point located just beneath the endothelial layer (third hyperreflective layer) (Fig. 1 ). 4) To calculate relative central epithelial thickness (RCET) and relative central stromal thickness (RCST), CET and CST were divided by CCT and then multiplied by 100. Of note, the minimum distance that can be measured between 2 points by this software is 4 mm. A single reader, who was masked to clinical data, analyzed all images. Intraobserver reliability for the corneal thickness parameter measurement was first evaluated and found to be excellent (intraclass correlation 0.97).
Main Outcome Measure
The main outcome measure was to study whether CET, CST, CCT, RCET and RCST differed by glaucoma status. Secondary outcome measures were correlations between other demographics and comorbidities with thickness measurements.
Statistical Data Analysis
All statistical analyses were performed using SPSS 21.0 (SPSS Inc, Chicago, IL) statistical package. Frequencies and descriptive statistics were applied to the data, as appropriate. To study the effect of glaucoma on corneal thickness parameters, subjects were first categorized by glaucoma status. Independent t tests were applied to assess differences in mean epithelial, stromal, and total corneal thickness between the groups. Subsequently, we evaluated which demographics, comorbidities, glaucoma metrics, and glaucoma medications were significantly associated with corneal thickness. Independent t tests, analyses of variance, and correlations (Pearson and Spearman) were used for statistical analysis, as applicable. Linear regression analyses were performed to evaluate which factors remained significantly associated with corneal thickness.
RESULTS
Study Population
A total of 116 right eyes of 116 males were included in this study; 58 eyes had a documented history of POAG, whereas 58 eyes had no history of POAG. The mean age of all participants was 68.2 6 10.6 (range 26-90) years. The majority of subjects were non-Hispanic (83%) and 48% were black. More than half of the group had hypertension (67%) and hyperlipidemia (67%), and 38% had diabetes.
Corneal Thickness Parameters in POAG Versus Healthy Controls
There were no significant differences in demographics (race, and ethnicity), and comorbidities (diabetes, hypertension, and hyperlipidemia) among the glaucoma and nonglaucoma groups. However, individuals in the glaucoma group were older (mean: 70.3 6 8.9 years) than those in the nonglaucoma group (mean: 66.0 6 11.7 years), P , 0.03. Individuals with glaucoma had lower mean CST (453.4 6 32.5 mm) and CCT (507.3 6 33.8 mm) compared with controls (CST: 465.2 6 31.2 mm and CCT: 521.5 6 31.5 mm), P = 0.05 and P = 0.02, respectively. CET measurements were also lower, but the difference did not reach statistical significance. However, we did not find any significant differences in RCET and RCST between the glaucoma group (RCET: 9.06 6 0.67, and RCST: 89.35 6 0.73) and the control group (RCET: 9.02 6 0.86, and RCST: 89.16 6 1.0), P = 0.77 and P = 0.24, respectively (Table 1) .
Glaucoma severity correlated with thickness, as those with severe glaucoma (n = 5) had the thinnest corneas (CST: 427.2 6 31.6 mm; CCT: 480.8 6 31.4 mm). Participants with moderate glaucoma (n = 39) had the second lowest values (CST: 453.5 6 32.3 mm; CCT: 507.5 6 33.6 mm) followed by those with mild glaucoma (n = 14) (CST: 462.5 6 30.2 mm; CCT: 516.2 6 32.2 mm) ( Table 2 ). In a similar manner, CST and CCT inversely correlated with the cup-todisc ratio (CDR) (r = 20.24 and r = 20.26), P = 0.009 and P = 0.001, respectively. However, IOP positively correlated with both CST and CCT (r = 0.18 and r = 0.19), P = 0.04 and P = 0.03, respectively. CET, RCET, and RCST did not correlate with glaucoma severity, CDR, or IOP (Table 3 ).
Corneal Thickness Parameters by Antiglaucoma Medications
CET, CST, and CCT were all negatively correlated with the number of antiglaucoma medications (r = 20.20, r = 20.22, and r = 20.25, respectively, P , 0.05 for all). There was no significant correlation between the number of antiglaucoma medications and RCET or RCST (Table 4) .
Changes in corneal thickness parameters by different types of antiglaucoma medications are summarized in (Table 4) . Considering only individuals with glaucoma, those using timolol eye drops had lower mean CET (45.0 6 3.0 mm) compared with individuals who did not use timolol (47.2 6 3.2 mm), P = 0.015. Both CST and CCT measurements were also lower, but the difference did not reach statistical significance. No significant differences were noted in corneal thickness parameters in those using versus not using dorzolamide, latanoprost, and brimonidine (Table 4) .
Corneal Thickness Parameters by Demographics and Comorbidities
Age was negatively correlated with RCET (r = 20.18, P = 0.047) but not CET (r = 20.15, P = 0.09), CST (r = 0.12, P = 0.18), or CCT (r = 0.09, P = 0.3). RCST was positively correlated with age (r = 0.21, P = 0.02) ( Table 3) . Blacks had lower CST (447.8 6 29.0 mm), CCT (503.0 6 30.5 mm), and RCST (89.01 6 0.80) compared with whites (CST: 470.0 6 31.7 mm, CCT: 525.1 6 32.4 mm, and RCST: 89.48 6 0.90), P = 0.0001, P = 0.0002, and P = 0.004, respectively. CET and RCET were not significantly affected by race. No significant differences in thickness were seen by ethnicity, diabetes, hypertension, and hyperlipidemia (Table 5) .
Regression Analysis
Multivariable regression analysis was performed to determine which factors remained significantly associated with corneal thickness. When considering demographics (age and race), glaucoma status (IOP, CDR, and stage), and antiglaucoma medications (number and type), the number of glaucoma medications remained significantly correlated with CET (beta: 20.20, SE: 0.21, P = 0.03). For CST, when considering these parameters, race (20.33, 5.7, 0.0002) and IOP (0.24, 0.72, 0.006) remained significant in the analysis (Table 6 ). When examining the relationship between corneal thickness and glaucoma within race, white individuals with glaucoma (n = 26) had thinner CST (464.2 6 32.3 mm) compared with their counterparts without glaucoma (n = 34) (CST: 474.4 6 30.9 mm), but the difference did not reach statistical significance (P = 0.21). Although blacks had lower CST values than whites, there were no significant differences in measurements between those with (n = 32) and without (n = 24) glaucoma (CST 444.7 6 30.4 mm; CST 452.0 6 27.1 mm), respectively (P = 0.35) (Fig. 2) .
DISCUSSION
This study aimed to investigate 5 specific corneal parameters: central CET, CST, total thickness (CCT), RCET, and RCST, assessing how these measurements differed with glaucoma status and topical medication use. We found an association between CCT and glaucoma, driven by CST rather than CET. Furthermore, similar to previous reports, 29, 30 we found a correlation between decreased CCT and increased glaucoma severity. However, when controlling for race, we found that black race was more significantly associated with CST than the presence or absence of glaucoma. Conversely, our results showed no significant correlation between relative corneal thickness measurements (RCET and RCST) and glaucoma. Although patients with glaucoma had lower absolute corneal thickness measurements compared with controls, the relative corneal thickness measurements were not different between the 2 groups. Similar to previous studies, 24, 25 we found that CST was the major contributor to CCT (about 90%), regardless of demographics, comorbidities, or glaucoma status. Our findings demonstrating an association between CCT and glaucoma are in line with those of previous reports. In one study of 50 individuals with glaucoma, CCT and CST, but not CET, showed a positive correlation with IOP (;r = 0.65). 31 Another study that compared eyes within an individual found that the eye with thinner CCT exhibited greater visual field loss compared with the eye with thicker CCT. 32 Yet another group described a similar phenomenon with respect to optic nerve cupping, but interestingly, did not note IOP differences by CCT. 33 As such, they hypothesized that the connection between CCT and glaucoma severity was driven by inaccuracies in IOP measurement. The finding of an association between black race and decreased CCT has likewise been described in previous studies. 11, 34, 35 Mechanisms underlying the lower CCT in blacks remain unknown but have been hypothesized to include genetic disposition and structural differences in the optic nerve. In fact, genetic predisposition has been shown to influence epithelial, stromal, and total corneal thickness. 36 For example, cell adhesion molecules, such as neurotrimin (NTM), contactin-associated protein-like 4 (CNTNAP4), and collagen genes, COL5A1 and COL8A2 have been implicated in CCT variability. 37 In mice, the genetic components that influence epithelial thickness seem to be different from those that influence stromal thickness. For example, the quantitative trait loci named Cctq5 (chr 11) and Cctq6 (chr 14) demonstrated an association specifically with ST, whereas Cctq4 (chr 3) correlated with epithelial thickness. It is clear then that CCT is a complex trait with multiple genes contributing to it, but the mechanisms connecting CCT to glaucoma needs further exploration.
In our study, CET negatively correlated with antiglaucoma medication use. Epithelial thickness is in part a measure of the number and regenerative capabilities of limbal epithelial stem cells. Over the course of a lifetime, the eye undergoes many periods of stress, during which time stem cells proliferate and reestablish normal homeostasis of epithelial thickness. Not surprisingly, as age increases, the number and proliferative capacity of these stem cells diminish, potentially leading to decreased epithelial thickness. 38 A similar phenomenon is found throughout the body with decreased function of epithelial stem cells on the skin and viscera, 23 leading to decreased epithelial thicknesses. For instance, age halts epithelial repair in the olfactory cells in a similar manner as the corneal epithelium. 39 Some previous studies have reported a negative association between age and absolute epithelial thickness, 38 whereas others have not. 40 The association between glaucoma medications and epithelial thickness may also be explained by the regenerative potential of limbal stem cells. Glaucoma medications contain preservatives, such as benzalkonium chloride, that are toxic to epithelial cells and can lead to a dysfunction or depletion of limbal stem cells. 41 Limitations of our study include a retrospective design and a male population defined by the availability of AS-OCT images. Furthermore, the OCT device used did not have automated software for measuring corneal thickness. However, we did find excellent intrareader reliability when measuring these parameters repeatedly within the same image. Despite these caveats, the study contributes vital information to the future of CCT interpretation in patients with glaucoma. Our results highlight that although CST is decreased in individuals with glaucoma compared with those without glaucoma, this difference is driven more by race than glaucoma status. Furthermore, our study highlights the potential effects of glaucoma medication usage, especially timolol, on central CET. 
